Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;20(10):685-695.
doi: 10.1038/s41569-023-00877-z. Epub 2023 May 16.

Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention

Affiliations
Review

Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention

Nathan D Wong et al. Nat Rev Cardiol. 2023 Oct.

Abstract

Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality in individuals with type 2 diabetes mellitus (T2DM). Secular changes in CVD outcomes have occurred over the past few decades, mainly due to a decline in the incidence of ischaemic heart disease. The onset of T2DM at a young age (<40 years), leading to a greater number of life-years lost, has also become increasingly common. Researchers are now looking beyond established risk factors in patients with T2DM towards the role of ectopic fat and, potentially, haemodynamic abnormalities in mediating important outcomes (such as heart failure). T2DM confers a wide spectrum of risk and is not necessarily a CVD risk equivalent, indicating the importance of risk assessment strategies (such as global risk scoring, consideration of risk-enhancing factors and assessment of subclinical atherosclerosis) to inform treatment. Data from epidemiological studies and clinical trials demonstrate that successful control of multiple risk factors can reduce the risk of CVD events by ≥50%; however, only ≤20% of patients achieve targets for risk factor reduction (plasma lipid levels, blood pressure, glycaemic control, body weight and non-smoking status). Improvements in composite risk factor control with lifestyle management (including a greater emphasis on weight loss interventions) and evidence-based generic and novel pharmacological therapies are therefore needed when the risk of CVD is high.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Blair, M. Diabetes mellitus review. Urol. Nurs. 36, 27–36 (2016). - PubMed
    1. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care 43, S14–S31 (2020).
    1. International Diabetes Federation. IDF Diabetes Atlas 10th Edition https://diabetesatlas.org/data/en/ (2021).
    1. Carracher, A. M., Marathe, P. H. & Close, K. L. International diabetes federation 2017. J. Diabetes 10, 353–356 (2018). - PubMed
    1. Gregg, E. W., Sattar, N. & Ali, M. K. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 4, 537–547 (2016). - PubMed

MeSH terms

LinkOut - more resources